Both enzymes were capable of converting (-)-matairesinol into (-)-pluviatolide by catalyzing methylenedioxy bridge formation, and did not act on other possible substrates tested. Interestingly, the enzymes described herein were highly similar to methylenedioxy bridgeforming enzymes from alkaloid biosynthesis, whereas candidates more similar to lignan biosynthetic enzymes were catalytically inactive with the substrates employed. This overall strategy has thus enabled facile further identification of enzymes putatively involved in (-)-podophyllotoxin biosynthesis, and underscores the deductive power of next generation sequencing and bioinformatics to probe and deduce medicinal plant biosynthetic pathways.
Massively parallel sequencing technologies (1) are rapidly evolving, and increasingly provide unprecedented opportunities to significantly enhance the understanding of biosynthetic processes, including those in important and yet poorly understood (non-model) medicinal plants. One main advantage is that such technologies can potentially lower the time frame for discovery of new genes and thus more rapidly improve our understanding of metabolism, e.g., when compared with more traditional approaches including labeled precursor administration, potential intermediate identification, enzyme purification and characterization, gene cloning, expressed sequence tag (EST) 2 libraries, etc. In this context, several recent investigations have used these massive parallel sequencing technologies to study a variety of non-model plants, with transcriptome assemblies mainly being generated from data from 454 and Illumina sequencing. Among others, these include Panax quinquefolius L. (2) , Panax ginseng (3), Gynostemma pentaphyllum (4), Phalaenopsis orchids (5, 6) , Camellia sinensis (7) , Catharanthus roseus (8) , Papaver somniferum (9) , Acacia auriculiformis and Acacia mangium (10) , Cicer arietinum (11) and Abies balsamea (12) . Although massive amounts of information can be obtained in this way, careful and informed analysis is required in order to help select candidate genes and carefully determine if they have a specific biosynthetic function of interest.
Podophyllum species produce the aryltetralin lignan, (-)-podophyllotoxin (1b), that is of great medicinal importance due to its extensive use in the semi-synthesis of the anticancer drugs, teniposide (2) , etopophos ® (3), and etoposide (4) (Fig. 1) . The latter are topoisomerase II inhibitors that are widely used for treating several cancers, including lung and testicular cancers (13) . However, as the main source of (-)-podophyllotoxin (1b), Podophyllum hexandrum is intensively collected and some reports suggest it has become endangered due to over-harvesting (14) .
While various synthetic chemical approaches to (-)-podophyllotoxin (1b) have been described, its production is not economical through such routes (15) (16) (17) . An alternative approach that may be more productive is to obtain it in higher amount via biotechnological manipulation, whether in cell culture or in whole plants. Yet, this is currently not possible as our knowledge of the (-)-podophyllotoxin (1b) biosynthetic pathway is still incomplete. Nevertheless, following monolignol formation, the entry point in its biosynthetic pathway occurs via stereoselective coupling of two E-coniferyl alcohol (5) derived free radicals, involving the participation of dirigent proteins (18) (19) (20) , to afford (+)-pinoresinol (6a) (Fig. 2) . The latter then undergoes enantiospecific reduction, via action of pinoresinol/lariciresinol reductase, to sequentially afford (+)-lariciresinol (7a) and (-)-secoisolariciresinol (8b). Stereospecific dehydrogenation next converts the latter into (-)-matairesinol (9b), the last unequivocal known step in (-)-podophyllotoxin (1b) biosynthesis (18, 21) . Several of these known steps have been subsequently confirmed using Podophyllum and Linum species (20, 22) . On the other hand, putative downstream steps converting (-)-matairesinol (9b) into (-)-podophyllotoxin (1b) have only been reported using crude enzymatic assays; no genes have yet been identified or the enzymes purified to homogeneity (23) (24) (25) (26) (27) .
The investigation herein describes the use of transcriptome sequencing using Illumina technologies and bioinformatics, together with metabolomic analysis, as a strategy to facilitate rapid gene discovery in (-)-podophyllotoxin (1b) biosynthesis. Specifically, this led to discovery of two new genes in P. hexandrum and P. peltatum, which encode enzymes capable of catalyzing methylenedioxy bridge formation through conversion of (-)-matairesinol (9b) into (-)-pluviatolide (14b).
EXPERIMENTAL PROCEDURES
Plant Material-Podophyllum hexandrum and Podophyllum peltatum plants were obtained from Digging Dog Nursery (Albion, CA) and Companion Plants (Athens, OH), respectively, and maintained in Washington State University greenhouse facilities.
Chemicals-(-)-Matairesinol (9b) (28), (-)-arctigenin (34b) and (+)-phillygenin (38a) (29) were isolated from Forsythia intermedia. (29) and (±)-piperitols (37a/b) (30) were synthesized as described. (-)--Conidendrin (36b) and (-)-5-methoxymatairesinol (35b) were a gift from Dr. Eric P. Swan (Forentek, Canada), whereas (-)-α-and (-)-β-peltatins (20b and 27b) were obtained from Dr. Paul M. Dewick (University of Nottingham, United Kingdom). (-)-Podophyllotoxin (1b) was purchased from Sigma-Aldrich.
Metabolite Extraction and Analysis-Rhizomes (for P. hexandrum), roots (for P. peltatum), stem and leaves (2 g, fresh weight) were individually harvested, immediately frozen in liquid nitrogen, ground to a fine powder and subsequently lyophilized. Each tissue was then successively sized via passage through a 150 m sieve and extracted with 10 l/mg methanol-water (7:3, v/v) with the corresponding extracts maintained at -80 °C until analysis. Samples were analyzed by liquid chromatography using a Waters Acquity ultra performance liquid chromatography system equipped with a Waters BEH C18 column (1.7 m particles, 2.1 × 50 mm) with a binary mobile phase of acetic acid-water (3:97) (A) and acetonitrile (B), with detection at 280 nm and by electrospray ionization mass spectrometry in the positive mode. The gradient program was as follows: flow rate of 0.3 ml/min; linear gradient of water with 0.1% formic acid: acetonitrile with 0.1% formic acid from 95:5 to 75:25 in 11 min, to 60:40 in 5 min, to 0:100 in 4 min, followed by 1.5 min at 0:100. The column temperature was held at 25 °C and sample injection volume was 5 l. Masses were determined using a Waters Xevo G2 Q-TOF mass spectrometer and using leucine-enkephalin as a lock-mass standard.
( Figure 4 for structures).
RNA Extraction and cDNA Preparation-Total RNA was individually isolated from 100 mg of flash frozen plant rhizome (for P. hexandrum), roots (for P. peltatum), stems and leaves using a Qiagen (Valencia, CA) RNeasy Mini kit according to the manufacturer's instructions, including the additional Qiagen clean-up protocol. An aliquot (1 g) of each was subsequently used for cDNA preparation. After DNAse I (Invitrogen) treatment, cDNA was prepared using SuperScript ® III FirstStrand Synthesis System according to the manufacturer's instructions and used for candidate gene amplification.
Transcriptome Sequencing and Library Assembly-Total RNA samples (~25 g) dissolved in water were evaluated for integrity using the Bioanalyzer 2100 (Agilent, CA, USA), with samples having an RNA integrity number (31) (RIN) >5.0 processed further. RNA sample concentrations were estimated using a RiboGreen assay in a Qubit fluorometer, and each was then processed using either Illumina RNA-Seq or Illumina TruSeq RNA sample preparation kits, according to Illumina protocols. Briefly, poly-A+ RNA was isolated from total RNA samples using oligo-d(T)25 magnetic beads (Dynabeads: Invitrogen, CA USA), then fragmented with the supplied reagents. First strand cDNA synthesis followed using random hexamers and the enzyme master mix provided. After second strand cDNA synthesis, the cDNA fragments were end-repaired by treatment with T4 DNA polymerase and Klenow fragment of E. coli DNA polymerase I, followed by addition of a single deoxyadenosine to the 3′ end of blunt-ended phosphorylated fragments. Sequencing adapters were attached with bacteriophage T4 ligase, followed by agarose gel electrophoresis with excision of fragments circa 500 bp in length. Each library DNA was purified from agarose using Qiagen QiaQuick gel extraction reagents, and subjected to 15 cycles of PCR. Amplified libraries were evaluated for quality and quantity using the Bioanalyzer 2100 and Nanodrop ND-1000 (Thermo Scientific, DE USA), respectively. Based on Nanodrop concentrations, libraries were normalized to 10 nM and accurate concentrations of sequenceable molecules were determined by qPCR using a reference library of known concentration as a standard. Flow cells were prepared on the Illumina Cluster Station and paired-end 54 bp sequence reads were obtained using an Illumina Genome Analyzer IIx instrument.
Initial read sets were examined for gross anomalies (e.g., over-represented reads due to library preparation issues), and for the presence of known sequencing artifacts, specifically phi X and known Illumina adapters. Read sets were then partitioned into collections of roughly one million reads, with these being quality trimmed using the FASTX Toolkit (http://hannonlab.cshl.edu/fastx_toolkit) at the level of phrap Q = 10.
Cleaned paired-end read data were next subjected to multiple assemblies using ABySS (32, 33) , run in parallel mode, over a range of kmers with 24 ≤ k ≤ 54. Contigs thus generated were named synthetic ESTs which in turn were created by performing multiple assemblies using different kmer sizes, pooling the resulting synthetic ESTs and, as described below, performing a subsequent assembly with a standard EST assembler. Typically this led to the production of at least twenty sets of synthetic ESTs.
Contigs resulting from each ABySS assembly were scaffolded using the ABySS scaffolder taking advantage of read pairing constraints. The NNN gap spacers inserted through scaffolding were resolved using GapCloser from the SOAPdenovo suite (34) , and synthetic EST sets, per kmer, were constructed from the resulting scaffolds of at least 80 nucleotides. All read data was incorporated in the assembly producing an overall transcript reference.
Final Assembly-Pooled synthetic EST sets were assembled using MIRA in EST assembly mode (35) . To control redundancy explicitly (at 98 percent sequence identity), the assembly results were processed with cd-hit (36) . Resulting contigs of at least 100 nucleotides were reported as the final contig set for the build. Manual assessments of the longest contigs, and contigs with anomalously low or high read counts, were performed by inspection of the pileup-view using Tablet (37) . Final assembly for all tissues and species investigated can be accessed in http://medplants.ncgr.org/.
Bioinformatic Analysis-Amino acid sequences of reference genes for shikimate, phenylpropanoid and lignan biosynthetic pathways were obtained from the NCBI database. Most genes were from Arabidopsis thaliana, except Petunia × hybrida for prephenate aminotransferase, Nicotiana tabacum for hydroxycinnamoyl CoA:shikimate hydroxycinnamoyl transferase, Forsythia × intermedia for dirigent protein and pinoresinol/ lariciresinol reductase and P. peltatum for secoisolariciresinol dehydrogenase and dirigent protein, respectively (supplemental Table S1 ). Amino acid sequences of each reference gene were applied to tblastn in BioEdit (Ver. 7.0.5.3, OCT. 28, 2005) (38) to search homologous genes against either P. hexandrum or P. peltatum contig databases. Some contigs with high homology (with identity ≥ 30% and E ≤ 5 × 10 -23 ) against each reference gene were selected and the respective ORFs for each contig determined using ORF Finder (NCBI). ORFs were individually translated into amino acid sequence using EMBOSS Transeq (European Bioinformatics Institute) and each amino acid sequence translation applied to tblastn (NCBI) to confirm whether it corresponded to each target gene. The procedures mentioned above were carried out to avoid ambiguity of chimeric contigs (39, 40) . In addition, E-values and identity (%) of each candidate gene were calculated using blastp (NCBI) against the amino acid sequence of the corresponding reference genes. Unknown candidate genes for (-)-podophyllotoxin (1b) biosynthesis were selected using the same approach, based on known sequences for cinnamate 4-hydroxylase (CYP73A1), p-coumaroyl CoA 3-hydroxylase (CYP98A44), ferulate 5-hydroxylase (CYP84A3), flavonoid 6-hydroxylase (CYP71D9), flavonoid 3′-hydroxylase (CYP75A1), corytuberine-synthase (CYP80G2) as well as the methylenedioxy bridgeforming enzymes piperitol/sesamin synthase CYP81Q1 (41) and (S)-canadine synthase CYP719 (42), respectively (supplemental Table  S2 ).
Gene Cloning and Yeast ExpressionCandidates for CyP450 genes were amplified from P. hexandrum cDNA using the primers described in Supplemental Table S2 . Amplification was performed using PfuTurbo DNA Polymerase (Agilent PCR) in a thermocycler with 35 cycles of 94 °C denaturing for 30 s, 55 °C annealing for 30 s, and 70 °C extension for 3 min and a final extension for 10 min. PCR products were resolved in 1 % agarose gels, where single bands of approximately 1,500 bp were obtained. Sequences were deposited in the GenBank TM database under accession numbers KC110988 -KC110998 (Supplemental Table S2 ).
Products were cloned into pENTR/D-TOPO (Invitrogen) and subsequently transferred to a yeast expression vector pYES-DEST52 (Invitrogen) according to the manufacturer's instructions. From P. hexandrum, yeast expression clones pYES-DEST52::CYP719A23, pYES-DEST52::CYP73A107 were obtained and from P. peltatum, pYES-DEST52::CYP719A24. Each was subsequently individually introduced in the Saccharomyces cerevisiae strain WAT11 (43), using the lithium acetate procedure according to the vector manufacturer's instructions. An empty vector pYES-DEST52 was also introduced into WAT11 and used as a negative control.
Transformed yeasts were selected using synthetic complete media lacking uracil (SC-U) plates with 2% agar and 2% glucose. Single colonies of transformed yeast were spiked in liquid SC-U (10 ml) containing 2% glucose, then grown overnight until O.D. 600 reached 3-4 and subsequently inoculated in Erlenmeyer flasks (1 l) containing induction media (200 ml SC-U with 1% raffinose and 2% galactose) to a final O.D. 600 of 0.05. Inductions were carried out for 24 h at 30 °C in an orbital shaker at 300 rpm until cells were harvested for immediate microsome preparation.
Microsomal Preparations-After induction, cells for each candidate recombinant enzyme were harvested by centrifugation at 3,900 × g for 10 min, then re-suspended in 3 ml per gram of cell weight Tris-HCl buffer (50 mM, pH 7.4) containing EDTA (1 mM), sorbitol (600 mM), DTT (0.1 mM) and PMSF (0.4 mM). Cells were disrupted using 0.5 mm glass beads (Biospec products, Inc.), with approximately half of the total volume added to cell suspensions in Falcon tubes (50 ml), by vortexing for 10 × 30 s at full speed with 30 s intervals on ice. Cell lysates were individually separated from glass beads by decantation, and glass beads were washed twice with half the total volume of buffer used initially to re-suspend the cells. Cell debris was removed by centrifugation at 15,000 × g for 10 min, and microsomal preparations were individually obtained as gelatinous pellets after ultracentrifugation of the supernatant at 91,000 × g for 75 min. Each microsomal fraction was resuspended in Tris-HCl buffer (50 mM, pH 7.4) containing EDTA (1 mM) and 30% glycerol (500 l per gram of fresh weight of cell harvested) and homogenized using a Dounce homogenizer. Microsomal preparations were kept at -80 °C for up to 8 weeks with no detectable loss in activity.
Enzymatic Assays-Assays were performed in sodium phosphate buffer (200 l, 100 mM and pH 7.5), with addition of a methanol solution of the substrates (10 l) at the desired concentration (from 0.1 mM to 25 mM), followed by NADPH (50 mM, 10 l) in sodium phosphate buffer (100 mM, pH 7.5) and finally the microsomal preparation (30 l) with a protein concentration of ~60 g/l. Upon addition of each microsomal preparation reaction, the mixtures were vortexed and incubated at 25 °C for 5 min with constant shaking. Reactions were individually terminated by addition of glacial acetic acid (10 l) and then centrifuged at 16,000 x g for 30 min. Aliquots of supernatant were then directly analyzed by ultra performance liquid chromatography using the same methodology described for metabolite analysis. For all kinetic data, assays were performed in three independent experiments. Kinetic parameters (K m and k cat ) were estimated by non-linear least-squares data fitting (44) and cytochrome P450 (CyP450) content in microsomes was determined by the reduced CO difference spectrum (45) using a Lambda 20 UVvisible spectrophotometer (Perking-Elmer). Isolation of Enzymatic Product-One hundred and fifty enzymatic assays using microsome preparations of yeast expressing CYP719A23 and with (-)-matairesinol (9b) as substrate were pooled together and the whole (~37.5 ml) extracted three times with chloroform (40 ml). The combined organic solubles were evaporated to dryness in vacuo, re-suspended in methanol (1 ml) and the enzymatically formed (-)-pluviatolide (14b) was next purified by HPLC using a SymmetryShield RP 18 column (Waters, 5 m particle size, 3.9 × 150 mm) eluted as follows: flow rate of 1 ml/min; linear gradient of water and acetonitrile from 9:1 to 4:6 in 25 min, to 1:0 in 2.5 min, followed by 4.5 minutes at 1:0. Fractions containing (-)-pluviatolide (14b) were pooled freeze-dried and subjected to 1 H, 13 C, and 1 H-13 C heteronuclear single quantum coherence NMR spectroscopic analyses using deuterated chloroform as solvent and tetramethylsilane as internal standard in a Varian VNMRS 600 MHz spectrometer (supplemental Table S3 and Figures  S1 -S3) . 
RESULTS AND DISCUSSION
Metabolite Profiling-First, metabolite profiling was carried out to ensure that target and biochemically related metabolites were present in the various tissues of the Podophyllum species investigated. Thus, utilizing ultra performance liquid chromatography-electrospray ionizationmass spectrometry, the extracts of rhizome (P. hexandrum), roots (P. peltatum), stem and leaves were examined. Based on metabolite UV, retention time and mass spectra, it was readily possible to detect and confirm the presence of the target metabolite, (-)-podophyllotoxin (1b). In P. hexandrum, it accumulates in higher amounts in the rhizome, being barely detectable in leaves and stem (Fig. 4) . In P. peltatum, the same trend was observed, with a higher accumulation in the roots although the stem and leaves also had (-)-podophyllotoxin (1b) contents closer to that in the roots. Its identification was performed by comparison with an authentic standard, having the same retention time as well as mass spectrum (Table 1 and Experimental Procedures). Other two related lignans, (-)-α-and (-)-ß-peltatins (20b and 27b), were detected in different tissues of both species and also identified using authentic standards (Table 1 and Experimental Procedures) . Interestingly, in P. hexandrum, the accumulation pattern of these two lignans was quite different from that observed for (-)-podophyllotoxin (1b), with (-)-α-peltatin (20b) being detected throughout all the different tissues. Conversely, there was a higher accumulation of (-)-ß-peltatin (27b) in the aerial tissues, especially in leaves (Fig. 4A) . In P. peltatum, on the other hand, both lignans accumulated in a somewhat similar pattern to that of (-)-podophyllotoxin (1b), with increasing amounts from leaves to stems and with the highest abundance in the roots (Fig. 4B) .
Based on the mass spectroscopic analyses (Table  1 (1), with higher amounts in the underground tissues in both species, especially in P. hexandrum. As for (-)-α-and (-)-β-peltatin glucosides (42b and 43b), they accumulated in all tissues, with slightly higher levels in the leaves (Fig. 4) .
Based on the metabolite profiles observed for (-)-podophyllotoxin (1b) and the other related lignans described above, it could be considered that the overall functional biosynthetic pathway leading to these lignans might be present in all tissues in both species; on the other hand, specific hydroxylation enzymes regiospecifically placing hydroxyl groups, leading either to (-)-podophyllotoxin (1b) or to (-)-α-and (-)-β-peltatin (20b and 27b), might be tissue specific.
Transcriptome Assembly and Analysis-Upon confirmation and analysis of metabolites as compared to authentic standards, RNA was extracted from tissues and transcriptome data was generated, as described in the Experimental Procedure section. From the crude RNA, poly-A+ RNA was isolated, fragmented and converted into cDNA using random hexamers and end-paired to increase data quality for later assembly. After addition of adapters and quality control of the products, sequencing was performed using the Illumina Genome Analyzer IIX generating the read sets. These first read sets were then examined for known anomalies like significant sequence similarity to either the phi X genome or the Illumina adapter reference set, and those anomalies were discarded; the initial data was thus slightly reduced, typically by 1-5 %. The reads were then partitioned in paired data blocks in order to take advantage of parallel processing in the workflow and subsequently assembled using ABySS, which provides the ability to associate input files of read data with their source library. In this step, kmer size tended to be the most sensitive factor in the construction and analysis of the de Bruijn graph, and different choices often led to similar, yet different, assemblies. Contigs from these assemblies tended to be 100-500 bp long, and were treated as "synthetic ESTs", and these were then assembled into the final contig set. It is important to stress that working with large quantities of data in this way presents a number of challenges, and for this reason each of the stages above includes a number of integrity checks (e.g., incomplete processing caused by system failures), basic data quality measurements (e.g., abundance of sequencing contaminants), and biological significance.
The transcriptome database assembled for P. hexandrum and P. peltatum produced final databases of 227,885 and 147,960 contigs, respectively, including several complete and incomplete ORFs. The transcriptome data obtained is available alongside that of other important medicinal plants and can be accessed in the following website: http://medplants.ncgr.org.
Next, comparative analysis of metabolite profiles and transcriptome assembly data from each of the various tissues [rhizomes (for P. hexandrum), roots (for P. peltatum), stems and leaves from both species] was carried out in order to: (a) verify whether known genes previously cloned from Podophyllum peltatum (18, 22) were correctly assembled; (b) identify candidate genes in the shikimate-chorismate pathway to phenylalanine, the entry point into the phenylpropanoid pathway and in the core phenylpropanoid pathway leading to monolignols, such as coniferyl alcohol (5) . The latter is also the entry point metabolite into the (-)-podophyllotoxin (1b) biosynthetic pathway; (c) conduct a bioinformatics analysis to identify potential candidate genes encoding steps beyond (-)-matairesinol (9b) and leading to the target compound, (-)-podophyllotoxin (1b).
Thus, assemblies were first interrogated in order to assess the validity of the presence of contigs corresponding to previously described genes and to obtain a first measure of the assembly quality. In our earlier studies of (-)-podophyllotoxin (1b) biosynthesis in P. peltatum, we had cloned and characterized a dirigent protein responsible for mediating the stereoselective coupling of Econiferyl alcohol (5) leading to (+)-pinoresinol (6a) (18) and a secoisolariciresinol dehydrogenase, responsible for the conversion of (−)-secoisolariciresinol (8b) into (−)-matairesinol (9b) (22) . When the assemblies obtained for P. peltatum were interrogated using these known sequences, contigs with very high identity (>98%) and low E value (<10 -110 ) to the previously described genes were observed (Table 2 ). This suggested that the assembly process was providing high quality data related to known genes; however, whether the sequences were fully correct or not (e.g., if they had point mutations, etc.) was not explored further, i.e., by confirmation through cloning, protein expression, etc.
The search for homologs in the shikimate/phenylpropanoid and monolignol forming pathways was also successful, with several homologs to each gene in both species identified. This included: 10 enzymes in the initial shikimate/chorismate pathway and 9 enzymes from the core phenylpropanoid pathway (supplemental Table S1 ) with identity ≥ 30% and E ≤ 5 × 10 -23 , as stated in the Experimental Procedure section. Overall, this successful search for homologs for all known genes from the shikimate/phenylpropanoid pathway that lead to the target lignans and several other important compounds (e.g., flavonoids, lignin, etc.) indicated that the assemblies obtained had a satisfactory coverage of the species transcriptomes. On the other hand, cloning and confirmation of the absolute accuracy of the assembly and the actual function of the corresponding gene was not carried out for non CyP450's as this was outside the scope of the current study.
Even considering the highly encouraging results from this initial assessment of the assembled datasets, the potential limitations of this overarching approach need to be considered. This is because the assembly protocol is a tradeoff of the stringency of the assembly and the length of the transcripts obtained. It is thus always possible to find chimeric contigs, especially in cases of highly similar transcripts (close homologs) or in those cases where repeating elements are present. On the other hand, if the stringency of the assembly procedure is increased to minimize the presence of chimeric contigs, the result can be an increase in the number of incomplete and redundant (more than one contig for the same transcript) contigs. During the assembly process, several parameters were thus optimized to reach a balance, but in the final assembly examples of both could still be observed.
CyP450's in Podophyllotoxin Biosynthesis: Once the quality of the assemblies was evaluated and validated in silico, a search for unknown putative genes involved in the last steps in (-)-podophyllotoxin (1b) biosynthesis was then undertaken.
The possible biochemical modifications required for conversion of (-)-matairesinol (9b) into (-)-podophyllotoxin (1b) are readily deduced (Fig. 2) , but the order of these reactions, on the other hand, has several possible permutations. Indeed, these could possibly either occur in parallel, in a biosynthetic "grid", or through a specific sequence of conversions (Fig.  2) . To verify the role of possible substrates, it would be necessary to test a variety of compounds, most of which are not commercially available. From (-)-matairesinol (9b), the biosynthetic pathway leading to (-)-podophyllotoxin (1b) can, however, be expected to include several CyP450's, involving two hydroxylations, one carbon-carbon (C-C) coupling/cyclization and methylenedioxy bridge formation, respectively (Fig. 2) . Additionally, while the C-C coupling and hydroxylation on the 7 position could be putatively performed by enzymes other than CyP450, (e.g., by a laccase in the first case and/or an oxoglutarate dependent dioxygenase for the latter), the formation of a methylenedioxy bridge functionality should be catalyzed by CyP450s. Accordingly, the first genes chosen for investigation were CyP450's. The CyP450's are a very large (e.g., more than 200 genes in A. thaliana) and diverse family of pivotal importance in plant secondary metabolism (49) (50) (51) . Many are involved in phenylpropanoid metabolism and have been identified, cloned, and characterized, from several plant species. More specifically, they can be employed in monolignol biosynthesis, where cinnamate-4-hydroxylase, pcoumaroyl CoA 3-hydroxylase and ferulate 5-hydroxylase are responsible for the successive hydroxylation of the C 6 C 3 core (52,53), as well as in the biosynthetic pathway leading to many downstream products, e.g., in flavonoid (54) and lignan (41, 55) biosynthesis.
The prediction of CyP450 physiological function is, however, frequently a difficult endeavor. This is because members of distinct gene families can perform similar functions and, in some cases, members of the same families can catalyze different reactions (51) . To increase the probability of obtaining the presumed CyP450's responsible for methylenedioxy bridge formation, several different known CyP450's were used as templates for the search of homologs that could be involved in (-)-podophyllotoxin (1b) and related phenylpropanoid biosynthesis. Initially focusing on P. hexandrum, its transcriptome was mined as described in the Experimental Procedure section for homologs to cinnamate 4-hydroxylase (CYP73A1), p-coumaroyl CoA 3-hydroxylase (CYP98A), ferulate 5-hydroxylase (CYP84A3), flavonoid 6-hydroxylase (CYP71D9), flavonoid 3′-hydroxylase (CYP75A1), corytuberine synthase (CYP80G2), (+)-δ-canadinene 8′-hydroxylase (CYP706B1), (S)-canadine synthase (CYP719) and piperitol/sesamin synthase (CYP81Q), respectively. The highest homology contigs in the assembled transcriptome were then selected for cloning and further analysis (supplemental Table  S2 ). All genes cloned matched transcriptome contig sequences perfectly (100%), therefore again validating the sequencing and assembly procedures employed.
Each of the above cloned candidates was heterologously expressed as described in the Experimental Procedure section for methylenedioxy bridge-forming enzymes and assayed against a range of possible substrates. The first genes to be tested encoded homologs of wellestablished enzymes CYP73A107 (cinnamate 4-hydroxylase homolog), CYP98A68 (p-coumaroyl CoA 3-hydroxylase homolog), CYP84A52 (ferulate 5-hydroxylase homolog) and CYP71BE30 (flavonoid 6-hydroxylase homolog); these CyP450's were assayed and found to carry out the anticipated enzymatic conversion (data not shown). CYP73A107 showed highest activity and was thus used as a positive control in all assays. We then proceeded to investigate the methylenedioxy bridge-forming steps of (-)-podophyllotoxin (1b) and related lignans.
Methylenedioxy Bridge Formation in Podophyllotoxin Biosynthesis-Methylenedioxy bridge formation by CyP450's has been described in isoflavonoid (56) , lignan (41, 55) and alkaloid (42, (57) (58) (59) biosynthesis, with encoding genes cloned and characterized. Transcriptome data was interrogated looking for sequences similar to either CyP450 families and we were able to identify putative methylenedioxy bridge-forming enzyme homologs to both lignan (CYP81Q1 and CYP81Q2) (41) and alkaloid (CYP719A1 and AY610513) (42, 57) biosynthesis.
In the assembled P. hexandrum transcriptome, there was one full length transcript with ~50% identity to the former, coded CYP81B57 (supplemental Table  S2 ), and another full length candidate with ~68% identity to the latter, coded CYP719A23 (Fig. 5) . Later, the P. peltatum assembled transcriptome was also interrogated and the transcript coded CYP719A24 was selected showing ~68% identity to CYP719A1 and ~96% identity to CYP719A23 (Fig. 5) .
These three candidates were cloned and their sequences confirmed by traditional Sanger sequencing (60). Subsequently, each was individually expressed in yeast and the corresponding recombinant proteins assayed for methylenedioxy bridge formation using a range of potential substrates and analogs thereof including (-)-matairesinol (9b), the last confirmed intermediate in ( piperitols (37 a/b) , and (+)-phillygenin (38a) have similar overall structure to possible intermediates and were tested in order to assess the enzymes' substrate versatility.
The first candidate evaluated was the homolog to the piperitol/sesamin synthase, namely CYP81B57. In our hands no catalytic activity could be observed, including towards piperitol/sesamin synthase natural substrates, (+)-pinoresinol (6a) and (+)-piperitol (37a) (data not shown).
We then proceeded to evaluate the methylenedioxy bridge-forming candidate homologs to the enzymes putatively annotated as involved in alkaloid biosynthesis. These (S)-canadine synthase homologs were found to act on (-)-matairesinol (9b), in the presence of NADPH, leading to the formation of a product with a longer retention time in ultra performance liquid chromatography analysis (Fig. 6A) , whose protonated molecular ion was at m/z 357 (Fig. 6C) , corresponding to the loss of two hydrogens as compared to (-)-matairesinol (9b) (Fig. 6B) . It was not possible to detect any activity and/or product formation, however, with the other putative substrates tested (data not shown), indicating that the (S)-canadine synthase homologs had a considerable degree of specificity towards (-)-matairesinol (9b). From the three possible products formed by a methylenedioxy bridgeforming enzyme (either with formation of one methylenedioxy bridge in either one of the aromatic rings or in both), the expected biosynthetic pathway reaction product to (-)-podophyllotoxin (1b) would be (-)-pluviatolide (14b) rather than (-)-haplomyrfolin (40b). In this respect, the fragmentation pattern of the enzymatic product was consistent to that described in the literature (61, 62) for (-)-pluviatolide (14b) (Fig.  7) . The product had a base peak of m/z 355.1183, corresponding to [M-H] -(calc. 355.1182) in the negative ion mode (data not shown). The positive ion mode spectrum was more informative (Fig.  6C) was also observed that allowed the distinction between the two potential isobaric products, (-)-pluviatolide (14b) and (-)-haplomyrfolin (40b) (Fig. 7) : this corresponds to the allylbenzodioxole fragment (calc. 161.0603) and shows that the methylenedioxy bridge was formed in the expected ring forming (-)-pluviatolide (14b), as the alternative product (-)-haplomyrfolin (40b) would produce a 4-allyl-2-methoxyphenol fragment of m/z 163.0754 (Fig. 7) . Therefore, the product obtained had the methylenedioxy bridge introduced into the correct aromatic ring. Analysis of the 1 H, 13 C, and HSQC NMR spectra of the enzymatically obtained product (see Supplementary material) also clearly supports the formation of the product, being in accordance with literature values (63), e.g., with the methylenedioxy bridge characteristic peaks at 5.9 and 101 ppm in 1 H-and 13 C-NMR spectra, respectively (supplemental Table S3 and Figures  S1 -S3 .
Kinetic Data of Putative Pluviatolide Synthase-Using (-)-matairesinol (9b) as a substrate, microsomes from S. cerevisiae expressing the P. hexandrum CYP719A23, with a concentration of 72 pmol as determined by analysis of the reduced CO binding spectrum (Fig.  8 B) , showed a saturation curve consistent with Michaelis-Menten kinetics with a K m of 9.7 ± 2.2 M (Fig. 8 A) and k cat of 14.9 ± 1.0 min -1 (Fig. 9  A) In addition, the homolog cloned from P. peltatum, CYP719A24, with a concentration of 26 pmol as determined by reduced CO binding spectrum (Fig. 8 C) displayed an apparent K m of 5.8 ± 1.4 M (Fig. 9 B) and k cat of 7.8 ± 0.4 min -1 . This tight binding towards (-)-matairesinol (9b) indicated that these CyP450s from both species can be provisionally presumed to be those involved in the methylenedioxy bridge formation leading to (-)-podophyllotoxin (1b) and pathway related lignans. Still, in order to determine if (-)-pluviatolide (14b) is the true biosynthetic intermediate, this will ultimately require in vivo verification e.g., by down-regulation or knockingout of this gene and identifying corresponding changes in metabolite profile. However, to date, there is no system in place to transform Podophyllum species.
It is very interesting that the candidates with highest homology to enzymes from alkaloid biosynthesis, the CYP719A1 (S)-canadine synthase (Fig. 10) , were found to be capable of performing the same reaction in lignan metabolism, while the candidate CYP81B57, closely related to the lignan piperitol/sesamin synthase from the Pedaliaceae, Sesamum indicum, had no activity detected. Podophyllum species, however, belong to the Berberidaceae family, and Ranunculales order, the only family with CYP719 genes described thus far (64) . The Podophyllum species also form a closely related phylogenetic group (65) with other species known for biosynthesizing similar aryltetralin lignans but with no alkaloids in them reported so far, such as Dysosma (66, 67) and Diphylleia (68) species. This clade forms a monophyletic group with many benzylisoquinoline alkaloid producing species (69), including those from which other CYP719s have been described. It can thus be tentatively postulated that this Podophyllum group has either no or strongly reduced alkaloid level of biosynthesis, while "recruiting" some of its genes for the podophyllotoxin pathway.
Conclusions-In this work, the utility of massively parallel sequencing was demonstrated for the study of non-model Podophyllum medicinal plants. The Illumina based technology produced abundant high quality data, with 100% agreement with sequences obtained from the cloned transcripts obtained using traditional Sanger sequencing. In addition to verifying the validity of known sequences in the lignan pathway leading to (-)-podophyllotoxin (1b), the two CyP450s from P. hexandrum and P. peltatum studied herein are putative pluviatolide-synthases, i.e., capable of catalyzing methylenedioxy bridge formation for (-)-podophyllotoxin (1b) biosynthesis.
As an extension of this work and as a resource for the scientific community, the transcriptome data and metabolic profiling of the species investigated in herein and several other important medicinal plants are available for the community in the open websites http://uic.edu/pharmacy/MedPlTranscriptome/inde x.html and http://medplants.ncgr.org. 
